Image-Based Phenotyping for Non-Destructive In Situ Rice (Oryza sativa L.) Tiller Counting Using Proximal Sensing

por Yamagishi, Yuki, Kato, Yoichiro, Ninomiya, Seishi, Guo, Wei
Publicado 2022

Development of a novel pink-eyed dilution mouse model showing progressive darkening of the eyes and coat hair with aging

por ISHIKAWA, Akira, SUGIYAMA, Makoto, HONDO, Eiichi, KINOSHITA, Keiji, YAMAGISHI, Yuki
Publicado 2015

Tumor Cells Detected in Retrieved Thrombus: Cancer-associated Stroke

por Nakanishi, Kaoru, Kawano, Hiroyuki, Yamagishi, Yuki, Kamma, Hiroshi, Shiokawa, Yoshiaki, Hirano, Teruyuki
Publicado 2021

GCT-34. ELUCIDATION OF THE MECHANISMS OF TUMORIGENESIS IN INTRACRANIAL GERM CELL TUMOR BY WHOLE GENOME SEQUENCE

por Yamagishi, Yuki, Takami, Hirokazu, Narushima, Daichi, Matsushita, Yuko, Sugihara, Eiji, Nishikawa, Ryo, Kato, Mamoru, Ichimura, Koichi
Publicado 2020

NQPC-5 Does high-dose methotrexate-based chemotherapy for relapsed primary CNS lymphoma increase a risk of leukoencephalopathy with prior whole brain radiotherapy?

por Kobayashi, Keiichi, Sasaki, Nobuyoshi, Saito, Kuniaki, Yamagishi, Yuki, Hanayama, Naomi, Nakatomi, Hirofumi, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2021

NQPC-21 QOL EVALUATION IN THE TREATMENT COURSE OF CNS LYMPHOMA

por Yamagishi, Yuki, Hanayama, Naomi, Sasaki, Nobuyoshi, Saito, Kuniaki, Kobayashi, Keiichi, Nakatomi, Hirofumi, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2022

NQPC-03 PROGNOSTIC SIGNIFICANCE OF QUALITY-OF-LIFE EVALUATION OVER TIME IN CLINICAL PRACTICE FOR PATIENTS WITH GLIOBLASTOMA

por Yamagishi, Yuki, Taku, Mikiko, Hanayama, Naomi, Saito, Kuniaki, Kobayashi, Keiichi, Yamada, Shin, Okajima, Yasutomo, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2019

ML-06 Diagnostic value of liquid biopsy for CNS lymphoma by detection of specific gene mutations in the cerebrospinal fluid

por Yamagishi, Yuki, Sasaki, Nobuyoshi, Matsushita, Yuko, Shimizu, Saki, Saito, Kuniaki, Kobayashi, Keiichi, Shiokawa, Yoshiaki, Nagane, Motoo, Ichimura, Koichi
Publicado 2020

ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma

por Kobayashi, Keiichi, Sasaki, Nobuyoshi, Saito, Kuniaki, Yamagishi, Yuki, Matsumoto, Yoshie, Sasaki, Yuta, Shimizu, Saki, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2020

ML-08 Safety and efficacy of consolidation cytarabine for newly-diagnosed primary central nervous system lymphoma

por Sasaki, Nobuyoshi, Kobayashi, Keiichi, Saito, Kuniaki, Sasaki, Yuta, Okamura, Yuma, Yamagishi, Yuki, Shimizu, Saki, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2020

ML-02 MULTIAGENT IMMUNOCHEMOTHERAPY, R-MPV-A, FOR PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA

por Nagane, Motoo, Kobayashi, Keiichi, Saito, Kuniaki, Shimada, Daisuke, Matsumoto, Yoshie, Iijima, Shohei, Sasaki, Nobuyoshi, Yamagishi, Yuki, Takayama, Nobuyuki, Shiokawa, Yoshiaki
Publicado 2019

ML-12 Clinical impact and management of skin-related disorders during treatment of relapsed PCNSL by tirabrutinib

por Sasaki, Nobuyoshi, Kobayashi, Keiichi, Saito, Kuniaki, Onoda, Ryo, Seiya, Yosuke, Suzuki, Saki, Yamagishi, Yuki, Nakatomi, Hirofumi, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2021

NQPC-06 FUNCTIONAL OUTCOMES OF INITIAL TREATMENTS FOR PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA ASSESSED BY ADL AND NEUROCOGNITIVE FUNCTION

por Taku, Mikiko, Kobayashi, Keiichi, Yamagishi, Yuki, Saito, Kuniaki, Shimada, Daisuke, Matsumoto, Yoshie, Kikuchi, Hana, Yamada, Shin, Shiokawa, Yoshiaki, Nagane, Motoo, Okajima, Yasutomo
Publicado 2019

ML-02 Chemotherapy for patients with relapsed or refractory primary CNS lymphoma

por Nagane, Motoo, Sasaki, Nobuyoshi, Kobayashi, Keiichi, Saito, Kuniaki, Shimada, Daisuke, Matsumoto, Yoshie, Iijima, Shohei, Yamagishi, Yuki, Shimizu, Saki, Sasaki, Yuta, Shiokawa, Yoshiaki
Publicado 2020

ML-18 High-dose chemotherapy supported by autologous stem cell transplant in relapsed and refractory primary CNS lymphoma

por Nagane, Motoo, Sasaki, Nobuyoshi, Saito, Kuniaki, Kobayashi, Keiichi, Onoda, Ryo, Seiya, Yosuke, Yamagishi, Yuki, Nakatomi, Hirofumi, Ohnishi, Hiroaki, Takayama, Nobuyuki, Shiokawa, Yoshiaki
Publicado 2021

Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma

por Yamagishi, Yuki, Sasaki, Nobuyoshi, Nakano, Yoshiko, Matushita, Yuko, Omura, Takaki, Shimizu, Saki, Saito, Kuniaki, Kobayashi, Keiichi, Narita, Yoshitaka, Kondo, Akihide, Shiokawa, Yoshiaki, Nagane, Motoo, Ichimura, Koichi
Publicado 2021

GEN-13 PAIRED MUTATIONAL ANALYSIS IN SECONDARY NERVOUS SYSTEM LYMPHOMA AND PCNSL SYSTEMIC RELAPSE REVEALS DRIVER MUTATION CANDIDATES IN THE CENTRAL NERVOUS SYSTEM

por Sasaki, Nobuyoshi, Kume, Satoshi, Tateishi, Kensuke, Nakamura, Taishi, Ibayashi, Kenji, Yamagishi, Yuki, Saito, Kuniaki, Kobayashi, Keiichi, Matsushita, Yuko, Hibiya, Yuko, Kitahara, Mai, Suzuki, Saki, Nagano, Reiko, Yamashita, Satoshi, Nakatomi, Hirofumi, Shiokawa, Yoshiaki, Ichimura, Koichi, Nagane, Motoo
Publicado 2022